Consolidated Balance Sheets - USD ($) $ in Thousands		Dec. 31, 2023	Dec. 31, 2022
Assets
Cash and cash equivalents		$ 52,591	$ 33,172
Federal funds sold		97,254	72,426
Investment securities		54,282	48,492
Equity investments		11,430	10,293
Loans		2,215,886	1,916,953
Allowance for credit losses	[1]	(84,235)	(63,845)	[2]
Net loans receivable		2,131,651	1,853,108
Goodwill		150,803	150,803
Intangible assets, net		20,591	22,035
Property, equipment, and right-of-use lease asset, net		14,076	13,168
Accrued interest receivable		13,538	12,613
Loan collateral in process of foreclosure	[3]	11,772	21,819
Income tax receivable		671	2,095
Other assets		29,168	19,855
Total assets		2,587,827	2,259,879
Liabilities
Deposits	[4]	1,866,657	1,607,110
Long-term debt	[5]	235,544	214,320
Deferred tax liabilities, net		21,207	26,753
Short-term debt		8,000	5,000
Operating lease liabilities		7,019	8,408
Accrued interest payable		6,822	4,790
Accounts payable and accrued expenses	[6]	30,804	22,974
Total liabilities		2,176,053	1,889,355
Commitments and contingencies
Stockholders’ equity
Preferred stock (1,000,000 shares of $0.01 par value stock authorized-none outstanding)		0	0
Common stock (50,000,000 shares of $0.01 par value stock authorized - 29,051,800 shares at December 31, 2023 and 28,663,827 shares at December 31, 2022 issued)		291	287
Additional paid in capital		288,046	283,663
Treasury stock (5,602,154 shares at December 31, 2023 and December 31, 2021)		(45,538)	(45,538)
Accumulated other comprehensive income (loss)		(3,696)	(3,349)
Retained earnings		103,883	66,673
Total stockholders’ equity		342,986	301,736
Non-controlling interest in consolidated subsidiaries		68,788	68,788
Total equity		411,774	370,524
Total liabilities and equity		$ 2,587,827	$ 2,259,879
Number of shares outstanding		23,449,646	23,061,673
Book value per share		$ 14.63	$ 13.08

[1] As of December 31, 2023 and 2022, there was no allowance for credit losses and net charge-offs related to the strategic partnership loans.

[2] Represents allowance prior to the adoption of ASU 2016-13.

[3] Includes financed sales of this collateral to third parties that are reported separately from the loan portfolio, and that are conducted by the Bank of $6.2 million and $7.5 million as of December 31, 2023 and 2022

[4] Includes $4.3 million and $3.8 million of deferred financing costs as of December 31, 2023 and 2022. Refer to Note 5 for more details

[5] Includes $4.2 million and $3.2 million of deferred financing costs as of December 31, 2023 and 2022. Refer to Note 5 for more details.

[6] Includes the short-term portion of lease liabilities of $2.5 million and $2.2 million as of December 31, 2023 and 2022. Refer to Note 6 for more details.